UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Beta-blocker therapy and impact on outcome after aneurysmal subarachnoid hemorrhage: a cohort study

Journal of neurosurgery, 2016-09, Vol.125 (3), p.730-736

2016

Volltextzugriff (PDF)

Single- and Multiple-Ascending-Dose Studies of the NS3 Protease Inhibitor Asunaprevir in Subjects with or without Chronic Hepatitis C

Antimicrobial Agents and Chemotherapy, 2012-04, Vol.56 (4), p.1838-1844

2012

Volltextzugriff (PDF)

Posaconazole Tablet Pharmacokinetics: Lack of Effect of Concomitant Medications Altering Gastric pH and Gastric Motility in Healthy Subjects

Antimicrobial agents and chemotherapy, 2014-07, Vol.58 (7), p.4020-4025

2014

Volltextzugriff (PDF)

The Pharmacokinetics of Taurolidine Metabolites in Healthy Volunteers

Journal of clinical pharmacology, 2007-06, Vol.47 (6), p.697-703

2007

Volltextzugriff (PDF)

Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome

Addiction (Abingdon, England), 2011-03, Vol.106 (3), p.574-580

2011

Volltextzugriff (PDF)

Population Pharmacokinetic Model of Sublingual Buprenorphine in Neonatal Abstinence Syndrome

Pharmacotherapy, 2015-07, Vol.35 (7), p.670-680

2015

Volltextzugriff (PDF)

Effects of aprepitant on the pharmacokinetics of ondansetron and granisetron in healthy subjects

Clinical therapeutics, 2003-05, Vol.25 (5), p.1407-1419

2003

Volltextzugriff (PDF)

Characterization of vaniprevir, a hepatitis C virus NS3/4A protease inhibitor, in patients with HCV genotype 1 infection: Safety, antiviral activity, resistance, and pharmacokinetics

Antiviral research, 2013-09, Vol.99 (3), p.214-220

2013

Volltextzugriff (PDF)

Effects of Ezetimibe on Cyclosporine Pharmacokinetics in Healthy Subjects

Journal of clinical pharmacology, 2006-03, Vol.46 (3), p.321-327

2006

Volltextzugriff (PDF)

MK-0448, a Specific Kv1.5 Inhibitor: Safety, Pharmacokinetics, and Pharmacodynamic Electrophysiology in Experimental Animal Models and Humans

Circulation. Arrhythmia and electrophysiology, 2012-12, Vol.5 (6), p.1193-1201

2012

Volltextzugriff (PDF)

A Two-Step Haploidentical Versus a Two-Step Matched Related Allogeneic Myeloablative Peripheral Blood Stem Cell Transplantation

Biology of blood and marrow transplantation, 2016, Vol.22 (1), p.141-148

2016

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of the novel PAR-1 antagonist vorapaxar in patients with end-stage renal disease

European journal of clinical pharmacology, 2012-07, Vol.68 (7), p.1049-1056

2012

Volltextzugriff (PDF)

The incidence of deep vein thrombosis detected by routine surveillance ultrasound in neurosurgery patients receiving dual modality prophylaxis

Journal of thrombosis and thrombolysis, 2011-08, Vol.32 (2), p.209-214

2011

Volltextzugriff (PDF)

Poor Positive Predictive Value of McConnell's Sign on Transthoracic Echocardiography for the Diagnosis of Acute Pulmonary Embolism

Hospital Practice, 2013-08, Vol.41 (3), p.23-27

2013

Volltextzugriff (PDF)

A five-year, retrospective, comparison review of survival in neurosurgical patients diagnosed with venous thromboembolism and treated with either inferior vena cava filters or anticoagulants

Journal of thrombosis and thrombolysis, 2007-12, Vol.24 (3), p.247-254

2007

Volltextzugriff (PDF)

Double-blind crossover study to assess potential differences in cytochrome P450 3A4 activity in healthy subjects receiving ondansetron plus dexamethasone, with and without aprepitant

Cancer chemotherapy and pharmacology, 2011-06, Vol.67 (6), p.1313-1321

2011

Volltextzugriff (PDF)

The Pharmacokinetics of Nebulized Nanocrystal Budesonide Suspension in Healthy Volunteers

Journal of clinical pharmacology, 2004-01, Vol.44 (1), p.67-72

2004

Volltextzugriff (PDF)

The effects of laropiprant, a selective prostaglandin D2 receptor 1 antagonist, on the antiplatelet activity of clopidogrel or aspirin

Platelets (Edinburgh), 2011-11, Vol.22 (7), p.495-503

2011

Volltextzugriff (PDF)

Effects of extended release niacin/laropiprant, laropiprant, extended release niacin and placebo on platelet aggregation and bleeding time in healthy subjects

Platelets (Edinburgh), 2010, Vol.21 (3), p.191-198

2010

Volltextzugriff (PDF)

Effect of Aprepitant on the Pharmacokinetics of Intravenous Midazolam

Journal of clinical pharmacology, 2007-06, Vol.47 (6), p.744-750

2007

Volltextzugriff (PDF)

Asthmatic Epithelial Cell Proliferation and Stimulation of Collagen Production . Human Asthmatic Epithelial Cells Stimulate Collagen Type III Production by Human Lung Myofibroblasts after Segmental Allergen Challenge

American journal of respiratory and critical care medicine, 2002-01, Vol.165 (2), p.266-272

2002

Volltextzugriff (PDF)

Heterogeneous Clearance of Antithymocyte Globulin after CD34 +-Selected Allogeneic Hematopoietic Progenitor Cell Transplantation

Biology of blood and marrow transplantation, 2005-08, Vol.11 (8), p.609-618

2005

Volltextzugriff (PDF)

The Effects of Modifying In Vivo Cytochrome P450 3A (CYP3A) Activity on Etoricoxib Pharmacokinetics and of Etoricoxib Administration on CYP3A Activity

Journal of clinical pharmacology, 2004-10, Vol.44 (10), p.1125-1131

2004

Volltextzugriff (PDF)

Relationship of Arachidonic Acid Concentration to Cyclooxygenase-Dependent Human Platelet Aggregation

Journal of clinical pharmacology, 2003-09, Vol.43 (9), p.983-989

2003

Volltextzugriff (PDF)

A glycosylated recombinant human granulocyte colony stimulating factor produced in a novel protein production system (AVI-014) in healthy subjects: a first-in human, single dose, controlled study

BMC clinical pharmacology, 2009-01, Vol.9 (2), p.2-2, Article 2

2009

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Aktive Filter

KollektionEBSCOhost Psychology and Behavioral Sciences Collection

PublikationsformReviews

PublikationsformArtikel

ThemaAdult

ThemaFemale

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(23)

Sprache

Englisch
(29)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

12 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Beta-blocker therapy and impact on outcome after aneurysmal subarachnoid hemorrhage: a cohort study

Single- and Multiple-Ascending-Dose Studies of the NS3 Protease Inhibitor Asunaprevir in Subjects with or without Chronic Hepatitis C

Posaconazole Tablet Pharmacokinetics: Lack of Effect of Concomitant Medications Altering Gastric pH and Gastric Motility in Healthy Subjects

The Pharmacokinetics of Taurolidine Metabolites in Healthy Volunteers

Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome

Population Pharmacokinetic Model of Sublingual Buprenorphine in Neonatal Abstinence Syndrome

Effects of aprepitant on the pharmacokinetics of ondansetron and granisetron in healthy subjects

Characterization of vaniprevir, a hepatitis C virus NS3/4A protease inhibitor, in patients with HCV genotype 1 infection: Safety, antiviral activity, resistance, and pharmacokinetics

Effects of Ezetimibe on Cyclosporine Pharmacokinetics in Healthy Subjects

MK-0448, a Specific Kv1.5 Inhibitor: Safety, Pharmacokinetics, and Pharmacodynamic Electrophysiology in Experimental Animal Models and Humans

A Two-Step Haploidentical Versus a Two-Step Matched Related Allogeneic Myeloablative Peripheral Blood Stem Cell Transplantation

Pharmacokinetics and pharmacodynamics of the novel PAR-1 antagonist vorapaxar in patients with end-stage renal disease

The incidence of deep vein thrombosis detected by routine surveillance ultrasound in neurosurgery patients receiving dual modality prophylaxis

Poor Positive Predictive Value of McConnell's Sign on Transthoracic Echocardiography for the Diagnosis of Acute Pulmonary Embolism

A five-year, retrospective, comparison review of survival in neurosurgical patients diagnosed with venous thromboembolism and treated with either inferior vena cava filters or anticoagulants

Double-blind crossover study to assess potential differences in cytochrome P450 3A4 activity in healthy subjects receiving ondansetron plus dexamethasone, with and without aprepitant

The Pharmacokinetics of Nebulized Nanocrystal Budesonide Suspension in Healthy Volunteers

The effects of laropiprant, a selective prostaglandin D2 receptor 1 antagonist, on the antiplatelet activity of clopidogrel or aspirin

Effects of extended release niacin/laropiprant, laropiprant, extended release niacin and placebo on platelet aggregation and bleeding time in healthy subjects

Effect of Aprepitant on the Pharmacokinetics of Intravenous Midazolam

Asthmatic Epithelial Cell Proliferation and Stimulation of Collagen Production . Human Asthmatic Epithelial Cells Stimulate Collagen Type III Production by Human Lung Myofibroblasts after Segmental Allergen Challenge

Heterogeneous Clearance of Antithymocyte Globulin after CD34 +-Selected Allogeneic Hematopoietic Progenitor Cell Transplantation

The Effects of Modifying In Vivo Cytochrome P450 3A (CYP3A) Activity on Etoricoxib Pharmacokinetics and of Etoricoxib Administration on CYP3A Activity

Relationship of Arachidonic Acid Concentration to Cyclooxygenase-Dependent Human Platelet Aggregation

A glycosylated recombinant human granulocyte colony stimulating factor produced in a novel protein production system (AVI-014) in healthy subjects: a first-in human, single dose, controlled study

Aktive Filter

Suchergebnisse filtern